The Extent and Implications of Poly-drug Use in Ireland
Keywords:
medicineAbstract
The phenomenon of poly-drug use is prevalent in Ireland. Statistics from the National Drug Treatment Reporting System show that this behaviour is increasing, from 5590 cases treated in 1998 to 7845 cases treated in 2002. The most frequent combinations include: heroin and cannabis when two drugs are implicated; heroin, methadone and benzodiazepines when three drugs are involved; and heroin, methadone, benzodiazepines and cannabis when four drugs are consumed. Opiate-related deaths account for the largest proportion of fatalities amongst drug users, with most of the deaths attributable to consumption of heroin in combination with benzodiazepines, alcohol, methadone and cocaine. There is a significant problem of driving under the influence of drugs in Ireland. Results of a nationwide survey carried out by the Medical Bureau of Road Safety demonstrates that there is a strong trend of increasing positive drug tests with decreasing levels of alcohol, 68% of drivers with blood alcohol concentrations below the legal limit were positive for one or more drugs. There is a need for treatment services dealing with poly-drug use as services in Ireland remain focussed on individual drugs of abuse.
References
http://www.who.int/substance_abuse/terminology/who_lexicon/en/print.html
2. Keogh E. Illicit Drug Use and Related Criminal Activity in the Dublin Metropolitan Area. Dublin: An Garda Siochana
1997.
3. Carr AJ, Hart I, Kelly MJ. Irish Drug Abusers: Their social background. Ir Med J 1980;73(12):453-457.
4. Bradshaw JS. Drug Misuse in Ireland,1982-83: Investigation in a North Central Dublin Area and in Galway, Sligo and
Cork. Dublin: Medico-Social Research Board, 1983.
5. Dean G, Bradshaw J, Lavelle P. Drug misuse in Ireland,1982-83. Investigation in a north central Dublin area and in
Galway, Sligo and Cork. Dublin: Medico-Social Research Board Dublin,1983.
6. Lavelle P. Heroin misuse in a North Central Dublin Area. A follow up on the 1982-83 Drug Misuse in Ireland Study.
Dublin: Medico-Social Research Board,1986.
7. Cassin S, Geoghegan T, Cox G. Young Injectors: A Comparative Analysis of Risk Behaviour. Ir J Med Sci
1998;167(4):234-237.
8. Centre for Health Promotion Studies, National University of Ireland, Galway. General health case study of te
Irish prison population. Dublin: Stationary House, 2000.
9. Long J, Lynn E, Kelly F. Occasional Paper No. 17. Trends in Treated Problem Drug Use in Ireland, 1998 to
2002. Dublin: Health Research Board, 2005.
10. Rooney S, Kelly G, Bamford L, Sloan D, O’ Connor JJ. Co-abuse of opiates and benzodiazepines. Ir J Med Sci
1998;168(1):36-41.
11. Browne R, Sloan D, Fahy S, Moran C, O’ Connor JJ. Detection of benzodiazepine use in opiate addicts. Ir Med J
1998;91;1;18-19.
12. Farrell M, Gerada C, Marsden J. External Review of Drug Services for the Eastern Health Board. London:
National Addiction Centre, Institute of Psychiatry, 2000.
13. EMCDDA. Mortality of drug users in the EU: Co-ordination of implementation of new cohort studies, follow
up and analysis of existing cohorts and development of new methods and outputs. Expert annual report, Lisbon,
2002.
14. Long J, Lynn, E, Keating J. Drug-related deaths in Ireland 1990-2002, Overview 1. Dublin: Health Research Board,
2005.
15. Corkery J, Schifano F, Ghodse H, Oyefeso A. The effects of methadone and its role in fatalities, Hum
Psychopharmacol 2004;19(8):565-576.
16. Byrne R. Opiate Related Deaths Investigated by the Dublin City and County Coroners in 1998,1999 and 2000.
Unpublished. Addiction Research Centre, Trinity College Dublin, 2001.
17.Cusack DA, Leavy CP, Daly, L, Fitzpatrick, P. Driving Under the Influence of Drugs in Ireland 2000-2001. Medical
Bureau of Road Safety, Department of Forensic Medicine & Department of Public Health Medicine and
Epidemiology, UCD, 2003.
18. Hansell S, White HR. Adolescent drug use, psychological distress and physical symptoms, J Health Soc Behav
1991;32(3):288-301.
19. Katz J, Terry P, Witkin JM Comparative behavioural pharmacology and toxicology of cocaine and its ethanol-derived
metabolite, cocaine ethyl-ester (cocaethylene). Life Sci 1992;50(18):1351-1361.
20. Girre C, Facy F, Lagier G, Dally S. Detection of blood benzodiazepines in injured people. Relationship with
alcoholism. Drug Alcohol Depend 1998;21(1):61-65.
21. Hollister LE. Interactions between alcohol and benzodiazepines. In: Galanter M, ed. Recent Developments in
Alcoholism: Vol 8. Combined Alcoholism and Other Drugs Dependence. 1990 New York: Plenum Press, 233-239.
22. Marijuana & Alcohol combined increase impairment. Traffic Tech 1999
http://www.nhtsa.dot.gov/people/outreach/traftech/pub/tt201.html
23. Ezechi OC, Kalu BK, Ezechi CO, Nwokoro CA, Ndububa VI, Okeke GC. Prevalence and pattern of domestic
violence against pregnant Nigerian women, J Obstet Gynecol 2004; 24(6):652-656.
24. McCance EF, Price LH, Kosten TR, Jatlow PI. Cocaethylene: pharmacology, physiology and behavioral effects in
humans. J Pharmacol Exp Ther 1995;274(1):215-223.
25. Corrigan D. Growing Cocaine Use Targeted by National Drugs Awareness Campaign 2005.
http://www.drugsinfo.ie/pressrel040705.htm.
26. Pennings EJ, Leccese AP. Wolff FA. Effects of concurrent use of alcohol and cocaine. Addiction 2002;97(7):773-783.
27. Ettenberg A. Opponent process properties of self administered cocaine, Neurosci Biobehav Rev 2004;27:721-728.
28. Jaffe JH. Drug addiction and drug abuse. In: Goodman A, Gilman TW, Nies AS, Taylor P eds. The Pharmacological
Basis of Therapeutics. 1992 New York: Mc Graw-Hill International: 542.
Downloads
Published
How to Cite
Issue
Section
License
Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
Provided they are the owners of the copyright to their work, authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgement of its initial publication in this journal.
